巴西五岁以下儿童国家肺炎球菌结合疫苗实施前后下呼吸道感染死亡率变化
该生态学研究评估巴西五岁以下儿童1990至2017年下呼吸道感染(LRI)死亡率趋势,以肺炎球菌脑膜炎(PM)和腹泻病(DD)分别作为阳性与阴性对照,采用全球疾病负担估计和Joinpoint回归分析。结果显示三种疾病死亡率均持续下降,但2010年全国实施PCV-10后LRI与PM的长期趋势无相关改变;LRI、PM、DD的最大年均百分比下降分别出现在2000至2003年(-8.3%)、1997至2000年(-11.9%)和1990至1994年(-13.8%)。结论认为死亡率下降与全国PCV-10实施无关,其他因素可能影响该长期趋势。
要点
- 巴西五岁以下儿童LRI、PM、DD死亡率在研究期间均持续下降。
- 2010年全国实施PCV-10后LRI与PM的长期趋势无相关改变。
- LRI最大年均下降-8.3%出现在2000至2003年,早于PCV-10实施。
核心结论
- 巴西LRI、PM和DD死亡率随时间下降,与全国PCV-10实施无关;医疗保健服务、社会经济状况改善和健康干预等其他因素可能影响了该长期趋势。
研究设计与样本
- 生态学研究,评估1990至2017年巴西五岁以下儿童死亡率,比较2010年全国PCV-10实施前后,采用全球疾病负担估计进行趋势分析,并使用Joinpoint回归模型描述趋势并识别统计学显著下降的时间点。
主要发现
- LRI、PM和DD死亡率均持续下降,PCV-10实施后LRI和PM的长期趋势无相关改变。
- LRI年均百分比下降最大为-8.3%(2000至2003年,p < 0.05),PM为-11.9%(1997至2000年,p < 0.05),DD为-13.8%(1990至1994年,p < 0.05)。
- LRI在1990至2009年的年均百分比变化为-5.9至-8.8,与PCV时代2010至2017年的-5.8至-7.8相当。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies on the impact of pneumococcal conjugate vaccines (PCV) on mortality, especially among preschoolers are scarce. We aimed to assess time trend mortality from lower respiratory infections (LRI), taken as a proxy of pneumonia, from 1990 to 2017. METHODS: This ecological study assessed the mortality rate among Brazilians under-five before and after the national PCV-10 implementation in 2010. Pneumococcal meningitis (PM) and diarrheal diseases (DD) were included as a "positive and negative controls", respectively. Trend analysis was performed through Global Burden of Disease estimates. Joinpoint regression modeling was used to describe trends in mortality and to identify time points of its statistically significant decreases throughout the study period. RESULTS: There was a sustainable reduction in mortality rates for these three diseases, with no relevant changes in the secular trends for LRI and PM after the PCV-10 implementation. For LRI, PM, and DD the higher and statistically significant (p < 0.05) annual percent change reduction occurred between 2000 and 2003, (-8.3%), 1997-2000 (-11.9%), and 1990-1994. (-13.8%), respectively, i.e., several years before the nationwide implementation of PCV-10. Moreover, for LRI the annual percent change (from -5.9 to -8.8) verified from 1990 to 2009, i.e., 20 years before countrywide vaccination, was comparable to that observed during the PCV era, that is, from minus 5.8 to minus 7.8, between 2010 and 2017. CONCLUSION: Mortality from LRI, PM, and DD decreased over time, irrespective of national PCV-10 implementation in Brazil. Other factors such as healthcare delivery, socioeconomic status improvement, and health interventions may have impacted this secular trend.
引用
- Camargos P, Nascimento-Carvalho CM, Teixeira R, et al. Lower respiratory infections mortality among Brazilians under-five before and after national pneumococcal conjugate vaccine implementation. Vaccine. 2020. PMID: 32033849. doi:10.1016/j.vaccine.2020.01.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。